In this study, we found that CAPE significantly ameliorates cognitive deficits accompanied by reduced levels of ROS and neuronal death in brain tissues and increased Nrf2/HO-1 expression in Aβ1-42O-treated mice. The gene discussed is HMOX1; the disease is Cognitive impairment.